Paxil News
Canada certifies class action Paxil birth defects lawsuit
A Canadian woman’s Paxil lawsuit has been certified as a class action, the first in Canada for birth defects related to antidepressants. Faith Gibson alleges that drug manufacturer GlaxoSmithKline failed to warn patients and doctors that its antidepressant Paxil could increase the risks of severe birth defects after her daughter was born with a hole in her heart. More »
Antidepressants linked to preterm birth, seizures
Antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which include Zoloft and Paxil, have been linked to premature births and seizures among infants, according to a new study. Researchers focused on nearly 230,000 Tennessee women who gave birth between 1995 and 2007. More »
Four Texas women file Paxil lawsuits
Four Texas women have filed Paxil lawsuits against the drug’s manufacturer alleging that the drug was responsible for their children’s birth defects. The women allege lawsuits that GlaxoSmithKline failed to properly warn them about the increased risk of birth defects associated with Paxil. More »
Pregnancy complications, birth defects linked to antidepressants
New research published in the Archives of General Psychiatry has revealed additional complications and birth defects related to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). The study of nearly 8,000 pregnant women in the Netherlands monitored possible abnormalities in children born to women on SSRIs such as Zoloft and Paxil. More »
Study reinforces link between SSRIs and birth defect
A study published in the British Medical Journal has found that taking a certain class of antidepressants during pregnancy can lead to persistent pulmonary hypertension of the newborn (PPHN), reinforcing findings from earlier studies. The study echoed the findings of previous research, which has also linked the use of antidepressants during pregnancy to an increased risk of birth defects. More »
Drugmaker to pay $3 billion to settle Avandia, Paxil lawsuits
British pharmaceutical giant GlaxoSmithKline (GSK) will pay more than $3 billion to settle a range of allegations related to its products. The company manufactures the popular antidepressant Paxil as well as the diabetes drug Avandia. More »
Study confirms link between autism and antidepressants
A new study has found that exposure to certain antidepressants before birth increases a child’s risk of being born with autism. The National Institute of Mental Health study found that rats exposed to a type of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during development were much more likely to show signs of autism. More »
Study uncovers link between Paxil, Zoloft and autism
A study published in the Archives of General Psychiatry has uncovered evidence linking antidepressants such as Paxil and Zoloft to an increased risk of autism. The study found that women who used a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs)—which includes the two drugs—were more likely to give birth to a child with autism spectrum disorders. More »
Lawsuit alleges Paxil maker failed to warn of birth defects risks
A lawsuit filed against the U.K.’s largest drugmaker, GlaxoSmithKline (GSK), has alleged that the company failed to properly warn consumers that its antidepressant drug Paxil could cause birth defects. The family of Anna Blyth alleges that their daughter’s birth defects were caused by her mother’s use of Paxil during pregnancy. The lawsuit also alleges that GSK knew as early as the 1980s that the antidepressant drug may be linked with an increased risk of birth defects. More »
FDA issues Paxil birth defects warning
In September 2005, the Food and Drug Administration warned that Paxil can double the risk of birth defects in children whose mothers took the antidepressant during the first trimester of pregnancy. The FDA stated that the Paxil warning label has been updated with information about the risks of taking the antidepressant during pregnancy. More »